August 5, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee Summary Minutes of the Drug Safety and Risk Management Advisory Committee Meeting August 5, 2013

First Page		Document Content
Health Autosomal dominant polycystic kidney Polycystic kidney disease Chronic kidney disease Renal failure Cystic kidney disease Tolvaptan Kidney Autosomal recessive polycystic kidney Kidney diseases Medicine Anatomy		August 5, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee Summary Minutes of the Drug Safety and Risk Management Advisory Committee Meeting August 5, 2013 Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 124,33 KB Share Document on Facebook

	RESEARCH ARTICLE Association of high serum triglycerides and triglycerides/ HDL ratio with raised HbA1c, creatinine, microalbuminuria and development of diabetic kidney disease and diabetic renal failure. Mathematical a DocID: 1vrv9 - View Document
	Chronic Renal Failure Information Guide DocID: 1tj2e - View Document
	Chronic Renal Failure Information Guide Also known as Chronic Kidney Disease Kidney functioning is calculated by glomerular filtration rate (GFR) 10% of people in U.S. aged 20 years of older DocID: 1tbXG - View Document
	Mild to Moderate Kidney Disease Study (MMKD) Principal Investigators: Florian Kronenberg Background and rationale for the MMKD Study: Chronic kidney disease (CKD) is a common condition and its prevalence is increasing. C DocID: 1qYPt - View Document
	Republic oftl.e Philippl11es ,_, PHILIPPINE HEALTH INSURANCE CORPORATION Citystate Centre, 709 Shaw Boulevard, Pasig City DocID: 1qNQ3 - View Document